Poll: Do You Agree with the FDA's Decision to Pull Avastin?

Article

This week the FDA pulled its accelerated approval of Avastin for women with HER2-negative metastatic breast cancer who have not undergone chemotherapy.

Everyone wants the best treatment available when it comes to cancer, breast cancer is no different. This week the FDA pulled its accelerated approval of Avastin for women with HER2-negative metastatic breast cancer who have not undergone chemotherapy. Avastin is still available for other types of cancer but because it is no longer approved for breast cancer insurance companies will not cover the approximately $8000.00 per month it costs. This puts breast cancer treatment out of reach for many women who say this was working for them.

Recent Videos
Evaluating a miniature robotic device for hysterectomy | Image Credit: linkedin.com.
Discussing low-dose aspirin use for preeclampsia prevention | Image Credit: komodohealth.com
Supreme Court upholds mifepristone access: Implications for women's health | Image Credit: linkedin.com
The significance of the Supreme Court upholding mifepristone access | Image Credit: unchealth.org
One year out: Fezolinetant displays patient satisfaction for managing hot flashes | Image Credit: sutterhealth.org
Addressing maternal health inequities: Insights from CDC's Wanda Barfield | Image Credit: cdc.gov
Addressing racial and ethnic disparities in brachial plexus birth Injury | Image Credit: shrinerschildrens.org
Related Content
Contemporary OB/GYN week in review: Paragard IUD, antenatal metformin, and more | Image Credit: © Aleksey 159 - © Aleksey 159 - stock.adobe.com.

Contemporary OB/GYN week in review: Paragard IUD, antenatal metformin, and more

Celeste Krewson, Assistant Editor
September 6th 2024
Article

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

Read More

Site Logo

How Individually Identifying More HPV Types Enables Better Patient Management and More Precise Care

September 29th 2023
Podcast

Listen

Study links prenatal fish intake to reduced autism risk | Image Credit: © New Africa - © New Africa - stock.adobe.com.

Study links prenatal fish intake to reduced autism risk

Joshua Fitch, Senior Editor
September 6th 2024
Article

A recent study reveals that consuming fish during pregnancy is associated with a reduced risk of autism in children, while omega-3 supplements show no significant benefit.

Read More

Site Logo

The Importance of Including Hemoglobinopathies as a Part of Carrier Screening Panels

September 15th 2023
Podcast

Listen

Antenatal metformin exposure not linked to adverse neurodevelopment | Image Credit: © BGStock72 - © BGStock72 - stock.adobe.com.

Antenatal metformin exposure not linked to adverse neurodevelopment

Celeste Krewson, Assistant Editor
September 5th 2024
Article

In a recent study, neurodevelopmental outcomes did not significantly differ among children exposed to metformin in utero vs those unexposed.

Read More

PFAS during pregnancy linked to obesity and heart issues | Image Credit: © Hunterframe - © Hunterframe - stock.adobe.com.

PFAS during pregnancy linked to obesity and heart issues

Celeste Krewson, Assistant Editor
September 5th 2024
Article

In a recent study, women with higher levels of per- and polyfluoroalkyl substances during pregnancy reported increased weight and body fat later in life.

Read More

© 2024 MJH Life Sciences

All rights reserved.